Thomas Eder
Vienna, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications
Mutant TP53 allelic states in human hematopoietic stem and progenitor cells.
Journal: Leukemia
Published: February 16, 2026
Preclinical models of hepatosplenic γδ T-cell lymphoma with an activating STAT5B mutation display sensitivity to JAK inhibitor upadacitinib.
Journal: HemaSphere
Published: October 27, 2025
Harnessing the E3 ligase SPOP for targeted degradation of the NUP98::KDM5A fusion oncoprotein.
Journal: Cell reports
Published: June 17, 2025
Clec12a is required for the pathogenesis of NUP98::NSD1 AML.
Journal: Blood advances
Published: December 27, 2024
Transcriptional and epigenetic rewiring by the NUP98::KDM5A fusion oncoprotein directly activates CDK12.
Journal: Nature communications
Published: March 06, 2024
A novel function of STAT3β in suppressing interferon response improves outcome in acute myeloid leukemia.
Journal: Cell death & disease
Published: December 14, 2023
RNA sequestration in P-bodies sustains myeloid leukaemia.
Journal: Nature cell biology
Published: September 18, 2023
Hyperactive STAT5 hijacks T cell receptor signaling and drives immature T cell acute lymphoblastic leukemia.
Journal: The Journal of clinical investigation
Published: January 04, 2023
Antiviral immune response reveals host-specific virus infections in natural ant populations.
Journal: Frontiers in microbiology
Published: December 12, 2022
TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression.
Journal: Nature communications
Published: November 02, 2022
Last Updated: 09/26/2026